NCT01869725
- Conditions
- Adenocarcinoma, Adult Medulloblastoma, Carcinoma, +25 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
Clinical trial condition
Carcinoma, Neuroendocrine
Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.
234 public trials
43 recruiting studies
Carcinoma, Neuroendocrine trial results
NCT00704730
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
- Locations
-
- University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
- TGEN Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Burbank, California, United States
NCT03072160
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT02514824
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00514046
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Novartis Investigative Site Essen, Germany
- Novartis Investigative Site Lausanne, Switzerland
- Novartis Investigative Site Zurich, Switzerland
NCT03538028
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
- Locations
-
- The Angeles Clinic and Research Center Los Angeles, California, United States
- Hackensack Medical Center Hackensack, New Jersey, United States
- Carolina BioOncology Institute Huntersville, North Carolina, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Completed
Nintedanib(BIBF1120) in Thyroid Cancer
NCT01788982
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- A.Z. St. Jan Bruges, Belgium
- Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- Universitair Ziekenhuis Antwerpen Edegem, Antwerpen, Belgium
NCT00454363
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +44 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT02101918
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +22 more
- Locations
-
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- M D Anderson Cancer Center Houston, Texas, United States